サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：足場技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年予測
市場調査レポート
商品コード
1332725

足場技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年予測

Global Scaffold Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
足場技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

足場技術の世界需要は、2022年の25億2,000万米ドルから2030年には74億6,000万米ドル近くの市場規模に達すると推定され、調査期間2023年～2030年のCAGRは14.5%です。

足場技術は、生物学および組織工学の文脈では、生体組織に見られる天然の細胞外マトリックス（ECM）を模倣できる人工的な環境を作り出すための支持構造またはフレームワークの使用を指します。これらの足場は、細胞の成長、組織化、分化を促進し、機能的な組織や臓器の開発につながるように設計されています。

市場力学：

慢性疾患の発生と高齢化人口の増加により、組織再生と臓器置換ソリューションの需要が高まっています。さらに、ドナー臓器の不足と組織工学の進歩が、代替となりうる足場ベースの療法への関心を高めています。足場材料の技術革新は、規制当局の支援やヘルスケア支出の増加とともに、足場技術の採用をさらに後押ししています。さらに、再生医療への投資が増加し、その利点に対する認識が高まっていることも、市場の拡大に寄与しています。足場ベースのアプローチによる個別化医療の可能性は、未充足の医療ニーズへの対応という点でも魅力を増しています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは足場技術の世界市場における各セグメントを包括的に評価することもできます。足場技術産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの足場技術市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 足場技術-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 足場技術の世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • ハイドロゲル（創傷治癒、3Dバイオプリンティング、免疫調節）
  • 高分子足場
  • 微細パターン表面マイクロプレート
  • ナノファイバーベース足場

第6章 足場技術の世界市場分析：疾患タイプ別

  • 疾患タイプ別概要
  • 実績データと予測データ
  • 疾患タイプ別分析
  • 整形外科、筋骨格系、脊椎
  • がん
  • 皮膚・内臓
  • 歯科
  • 心臓・血管
  • 神経学
  • 泌尿器科
  • 消化器・婦人科
  • その他

第7章 足場技術の世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 幹細胞治療（再生医療、組織工学）
  • 創薬
  • その他

第8章 足場技術の世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • バイオテクノロジーおよび製薬機関
  • 研究機関・研究所
  • 病院・診断センター
  • その他

第9章 足場技術の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績および予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績および予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績および予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績および予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績および予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第10章 足場技術企業の競合情勢

  • 足場技術市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Tecan Trading AG
  • REPROCELL Inc.
  • 3D Biotek LLC
  • Becton
  • Dickinson and Company
  • Medtronic
  • Xanofi
  • Molecular Matrix Inc.
  • Matricel GmbH
  • Pelobiotech
  • 4titude
  • Corning Incorporated
  • Akron Biotech
  • Avacta Life Sciences Limited.
  • Vericel Corporation
  • NuVasive Inc.
  • Allergan

注-企業プロファイルにおいて、財務の詳細や最近の動向は、入手可能な情報に基づいているか、非公開会社の場合はカバーしていない可能性があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Hydrogels (Wound Healing, 3D Bioprinting, Immunomodulation) Market Sales by Geography (USD MN)
  • Polymeric Scaffolds Market Sales by Geography (USD MN)
  • Micropatterned Surface Microplates Market Sales by Geography (USD MN)
  • Nanofiber Based Scaffolds Market Sales by Geography (USD MN)
  • Analysis Market by Disease Type (USD MN)
  • Orthopedics, Musculoskeletal, & Spine Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Skin & Integumentary Market Sales by Geography (USD MN)
  • Dental Market Sales by Geography (USD MN)
  • Cardiology & Vascular Market Sales by Geography (USD MN)
  • Neurology Market Sales by Geography (USD MN)
  • Urology Market Sales by Geography (USD MN)
  • GI, Gynecology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Stem Cell Therapy (Regenerative Medicine, & Tissue Engineering) Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-Use (USD MN)
  • Biotechnology & Pharmaceutical Organizations Market Sales by Geography (USD MN)
  • Research Laboratories & Institutes Market Sales by Geography (USD MN)
  • Hospitals & Diagnostic Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Scaffold Technology Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Scaffold Technology Report
  • Market Research Process
  • Market Research Methodology
  • Global Scaffold Technology Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Disease Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Hydrogels (Wound Healing, 3D Bioprinting, Immunomodulation) Market Sales by Geography (USD MN)
  • Polymeric Scaffolds Market Sales by Geography (USD MN)
  • Micropatterned Surface Microplates Market Sales by Geography (USD MN)
  • Nanofiber Based Scaffolds Market Sales by Geography (USD MN)
  • Global Market Analysis by Disease Type (USD MN)
  • Orthopedics, Musculoskeletal, & Spine Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Skin & Integumentary Market Sales by Geography (USD MN)
  • Dental Market Sales by Geography (USD MN)
  • Cardiology & Vascular Market Sales by Geography (USD MN)
  • Neurology Market Sales by Geography (USD MN)
  • Urology Market Sales by Geography (USD MN)
  • GI, Gynecology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Stem Cell Therapy (Regenerative Medicine, & Tissue Engineering) Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Biotechnology & Pharmaceutical Organizations Market Sales by Geography (USD MN)
  • Research Laboratories & Institutes Market Sales by Geography (USD MN)
  • Hospitals & Diagnostic Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112111784

The global demand for Scaffold Technology Market is presumed to reach the market size of nearly USD 7.46 BN by 2030 from USD 2.52 BN in 2022 with a CAGR of 14.5% under the study period 2023 - 2030.

Scaffold technology, in the context of biology and tissue engineering, refers to the use of supportive structures or frameworks to create artificial environments that can mimic the natural extracellular matrix (ECM) found in living tissues. These scaffolds are designed to facilitate the growth, organization, and differentiation of cells, leading to the development of functional tissue or organs.

MARKET DYNAMICS:

Chronic disease occurrence and the growing ageing population have heightened the demand for tissue regeneration and organ replacement solutions. Additionally, the shortage of donor organs and the advancements in tissue engineering have fueled interest in scaffold-based therapies as potential alternatives. Technological innovations in scaffold materials, along with regulatory support and rising healthcare expenditure, further boost the adoption of scaffold technology. Moreover, increased investment in regenerative medicine and growing awareness of its benefits have contributed to the market's expansion. The potential for personalized medicine through scaffold-based approaches adds to its appeal in addressing unmet medical needs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of scaffold technology. The growth and trends of scaffold technology industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the scaffold technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Hydrogels (Wound Healing, 3D Bioprinting, Immunomodulation)
  • Polymeric Scaffolds
  • Micropatterned Surface Microplates
  • Nanofiber Based Scaffolds

By Disease Type

  • Orthopedics (Musculoskeletal, & Spine)
  • Cancer
  • Skin & Integumentary
  • Dental
  • Cardiology & Vascular
  • Neurology
  • Urology
  • GI, Gynecology
  • Others

By Application

  • Stem Cell Therapy (Regenerative Medicine, & Tissue Engineering)
  • Drug Discovery
  • Others

By End-Use

  • Biotechnology & Pharmaceutical Organizations
  • Research Laboratories & Institutes
  • Hospitals & Diagnostic Centers
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Scaffold Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Scaffold Technology market include Thermo Fisher Scientific, Inc., Merck KGaA, Tecan Trading AG, REPROCELL Inc., 3D Biotek LLC, Becton, Dickinson and Company, Medtronic, Xanofi, Molecular Matrix, Inc., Matricel GmbH, Pelobiotech, 4titude, Corning Incorporated, Akron Biotech, Avacta Life Sciences Limited., Vericel Corporation, NuVasive, Inc., Allergan. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SCAFFOLD TECHNOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Disease Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SCAFFOLD TECHNOLOGY MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Hydrogels (Wound Healing, 3D Bioprinting, Immunomodulation) Historic and Forecast Sales by Regions
  • 5.5 Polymeric Scaffolds Historic and Forecast Sales by Regions
  • 5.6 Micropatterned Surface Microplates Historic and Forecast Sales by Regions
  • 5.7 Nanofiber Based Scaffolds Historic and Forecast Sales by Regions

6 . GLOBAL SCAFFOLD TECHNOLOGY MARKET ANALYSIS BY DISEASE TYPE

  • 6.1 Overview by Disease Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Disease Type
  • 6.4 Orthopedics, Musculoskeletal, & Spine Historic and Forecast Sales by Regions
  • 6.5 Cancer Historic and Forecast Sales by Regions
  • 6.6 Skin & Integumentary Historic and Forecast Sales by Regions
  • 6.7 Dental Historic and Forecast Sales by Regions
  • 6.8 Cardiology & Vascular Historic and Forecast Sales by Regions
  • 6.9 Neurology Historic and Forecast Sales by Regions
  • 6.10. Urology Historic and Forecast Sales by Regions
  • 6.11 GI, Gynecology Historic and Forecast Sales by Regions
  • 6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL SCAFFOLD TECHNOLOGY MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Stem Cell Therapy (Regenerative Medicine, & Tissue Engineering) Historic and Forecast Sales by Regions
  • 7.5 Drug Discovery Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL SCAFFOLD TECHNOLOGY MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-Use
  • 8.4 Biotechnology & Pharmaceutical Organizations Historic and Forecast Sales by Regions
  • 8.5 Research Laboratories & Institutes Historic and Forecast Sales by Regions
  • 8.6 Hospitals & Diagnostic Centers Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL SCAFFOLD TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE SCAFFOLD TECHNOLOGY COMPANIES

  • 10.1. Scaffold Technology Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF SCAFFOLD TECHNOLOGY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Merck KGaA
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Tecan Trading AG
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. REPROCELL Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. 3D Biotek LLC
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Becton
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Dickinson and Company
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Medtronic
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Xanofi
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Molecular Matrix Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Matricel GmbH
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Pelobiotech
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. 4titude
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Corning Incorporated
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. Akron Biotech
    • 11.17.1. Company Overview
    • 11.17.2. Company Revenue
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. Avacta Life Sciences Limited.
    • 11.18.1. Company Overview
    • 11.18.2. Company Revenue
    • 11.18.3. Products
    • 11.18.4. Recent Developments
  • 11.19. Vericel Corporation
    • 11.19.1. Company Overview
    • 11.19.2. Company Revenue
    • 11.19.3. Products
    • 11.19.4. Recent Developments
  • 11.20. NuVasive Inc.
    • 11.20.1. Company Overview
    • 11.20.2. Company Revenue
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.21. Allergan
    • 11.21.1. Company Overview
    • 11.21.2. Company Revenue
    • 11.21.3. Products
    • 11.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies